Loading... Please wait... Loading... Please wait...
ESTIMATED
05/01/2024
05/01/2024
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 4 | $1.70 | $1.70 | $1.70 |
| Q2 2024 | 16 | $1.64 | $2.01 | $1.76 |
| Q3 2024 | 7 | $1.98 | $1.98 | $1.98 |
| Q4 2024 | 13 | $1.92 | $1.92 | $1.92 |
| Q1 2025 | 10 | $1.50 | $1.50 | $1.50 |
| Q2 2025 | 8 | $2.05 | $2.05 | $2.05 |
| Q3 2025 | 8 | $2.14 | $2.14 | $2.14 |
| Q4 2025 | 14 | $2.09 | $2.09 | $2.09 |
| Q1 2026 | 9 | $1.72 | $1.72 | $1.72 |
| Q2 2026 | 7 | $2.26 | $2.26 | $2.26 |
| Q3 2026 | 7 | $2.36 | $2.36 | $2.36 |
| Q4 2026 | 13 | $2.28 | $2.28 | $2.28 |
CVS Health Corporation last posted its earnings results on Wednesday, May 1st, 2024. The company reported $1.31 earnings per share for the quarter, missing analysts' consensus estimates of $1.7 by $0.39. The company had revenue of 88.44 B for the quarter and had revenue of 357.78 B for the year. CVS Health Corporation has generated $6 earnings per share over the last year ($6.47 diluted earnings per share) and currently has a price-to-earnings ratio of 10.01. CVS Health Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/01/2024 | Q1 2024 | $1.70 | $0.88 | -0.82 | $89.33 B | $88.44 B | 02/07/2024 | Q4 2023 | $2.01 | $1.59 | -0.42 | $90.56 B | $93.81 B | 11/01/2023 | Q3 2023 | $2.13 | $1.76 | -0.37 | $89.76 B | 08/02/2023 | Q2 2023 | $2.12 | $1.48 | -0.64 | $88.92 B | 05/03/2023 | Q1 2023 | $2.07 | $1.66 | -0.41 | $80.69 B | $85.28 B | 02/08/2023 | Q4 2022 | $1.92 | $1.76 | -0.16 | $76.43 B | $83.85 B | 11/02/2022 | Q3 2022 | $1.99 | -$2.59 | -4.58 | $81.16 B | 08/03/2022 | Q2 2022 | $2.17 | $2.25 | 0.08 | $80.64 B | 05/04/2022 | Q1 2022 | $2.15 | $1.76 | -0.39 | $76.83 B | 02/09/2022 | Q4 2021 | $1.94 | $0.99 | -0.95 | $75.66 B | $76.60 B | 11/03/2021 | Q3 2021 | $1.79 | $1.21 | -0.58 | $70.52 B | $73.79 B | 08/04/2021 | Q2 2021 | $2.06 | $2.11 | 0.05 | $70.24 B | $72.62 B | 05/04/2021 | Q1 2021 | $1.72 | $1.69 | -0.03 | $69.10 B | 02/16/2021 | Q4 2020 | $1.24 | $0.74 | -0.5 | $68.73 B | $69.55 B | 11/06/2020 | Q3 2020 | $1.34 | $0.93 | -0.41 | $66.62 B | $67.06 B | 08/05/2020 | Q2 2020 | $1.93 | $2.27 | 0.34 | $64.00 B | $65.34 B | 05/06/2020 | Q1 2020 | $1.63 | $1.54 | -0.09 | $66.76 B | 02/18/2020 | Q4 2019 | $1.34 | $63.93 B | $66.89 B | 11/06/2019 | Q3 2019 | $1.77 | $1.17 | -0.6 | $63.02 B | $64.81 B | 08/07/2019 | Q2 2019 | $1.69 | $1.49 | -0.2 | $62.63 B | $63.43 B |
|---|
A. CVS Health Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off last year's report dates.
A. The conference call for CVS Health Corporation's latest earnings report can be listened to online.
A. The conference call transcript for CVS Health Corporation's latest earnings report can be read online.
A. CVS Health Corporation (NYSE:CVS) has a recorded annual revenue of $357.78 B.
A. CVS Health Corporation (NYSE:CVS) has a recorded net income of $357.78 B. CVS Health Corporation has generated $6.49 earnings per share over the last four quarters.
A. CVS Health Corporation (NYSE:CVS) has a price-to-earnings ratio of 10.01 and price/earnings-to-growth ratio is 2.29.
